A new robotic system at Ochsner is reducing risks associated with lung biopsies and helping patients become surgical candidates sooner.

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...

Researchers at Northern Arizona University (NAU) are testing a new approach that could make it easier for clinicians to spot ...

CareDx, Inc. reports its first net profit in a decade with improved cash flow and margins. Click for this updated look at CDNA stock prospects.

M42 is committed to the sustainable future of global health – from Abu Dhabi to the world. The company’s strategy involves leveraging technology not as a mere tool but as a transformative force in ...

New Cancer Center at Jefferson Hospital looks to fill rural gap with specialized care and wide range of expertise.

When Leslie Keebler contracted the flu last winter, early-stage lung cancer was not on her radar. The 62-year-old from ...

Lung cancer screening can detect cancer early when it’s most treatable. See if you qualify for a low-dose CT scan at Fred Hutch.

A UK research team has developed a pioneering blood test that could change the way lung cancer is detected and monitored.

Explore the role of patient-derived biology in enhancing antibody-drug conjugates for more effective cancer treatment.

VolitionRx Limited ("Volition"), a multi-national epigenetics company, issues a Business Review of 2025. Review of the Year by Cameron Reynolds, Group Chief Executive OfficerAs 2025 draws to a close, ...